Schedule & Agenda

Full schedule & agenda from the 2019 BIO International Convention.

2019 Schedule & Agenda

Below is a complete list of the programming and events from the 2019 BIO International Convention. Stay tuned for announcements about the 2020 BIO International Convention schedule and agenda in March 2020.

BIO International Convention
Date
  • Show All
Time
  • Show All
  • Show All
  • Show All
Jump to Day
126 Results
Monday, June 3
1:00 PM - 2:15 PM
As noted in the BRAIN 2025 report, the burden of human brain disorders is significant. Over five…
For some patients with no hope, the potential of gene therapy represents a light at the end of the…
In May, the Trump Administration issued its “American Patients First” drug pricing blueprint, aimed…
Over the past three decades, Congress and the FDA have put in place several programs to drive…
Last year, Immuno-oncology (I/O) drove nearly 30% of licensing activity in Oncology while half of…
The expansion of new drug modalities and growth of precision medicine create new challenges and…
1:15 PM - 1:45 PM
Chris has spent his career in the Senate focused on working across the aisle to get things done for…
2:30 PM - 3:45 PM
Academic science is arguably the greatest source of innovation in our ecosystem, yet faces…
What you have to say in 30 seconds could mean the difference between a meeting with an investor…
Our industry has been shaped by an ever-changing landscape, with emerging science disrupting the…
Current investment in antimicrobial R&D is insufficient to address growing resistance. US…
Scientific technology for gene therapy has made tremendous progress and the regulatory landscape is…
Developments in biologics are of ever-increasing focus in drug development. Unlike more traditional…
As healthcare shifts towards digital, the spotlight is shining on the emerging field of Digital…
At the Biomedical Advanced Research and Development Authority, BARDA, We are innovating not only in…
2:30 PM - 4:45 PM
Join us for a viewing of the movie 'Turning Point' and a discussion with advocates and researchers,…
4:00 PM - 5:00 PM
Reproducibility is a foundational element of the scientific method, a benchmark upon which the…
Despite advances in many drug research paradigms - DNA sequencing, high throughput screening and…
At the NIH, SBIR/STTR spending limits have increased to more than $1B in 2018. SBIR eligibility…
With the recent approvals of gene therapies and more on the horizon, panelists will look to explore…
The Biologics Price Competition and Innovation (BPCIA) was passed as part of the Affordable Care…
We have all heard the statistics - 19% of clinical trials terminate due to failed recruitment or…
Digital health technologies are increasingly being used for drug discovery, development, evidence…
One of the unique challenges affecting the development of new vaccines and therapeutics against…
Tuesday, June 4
11:00 AM - 12:15 PM
In recent years, there’s been a scarcity of high quality, revenue-generating biopharma assets. This…
Value-based payment (VBP) arrangements, which align payments to observed value and outcome in a…
The petrochemical industry spent the better part of the 20th century perfecting distillation for…
Too many emerging technologies get lost in translation, so new models are needed to help academic…
Drug overdose deaths including those involving opioids has continued to increase, reaching 42,000…
Globally, about 17 million people suffer a stroke each year, more than all dementias combined,…
Women graduate college at higher rates than men and make up nearly half the US workforce, yet only…
This session will showcase new scientific and clinical data on novel vaccines and immunotherapies…
The requirements for patenting life science inventions under the European Patent Convention (EPC)…
How do you develop the right leadership and organizational capabilities that will enable your…
Attracting even 1% of the $200B annualized global biopharmaceutical investment may translate into …
Recently, we have seen strong progress in the application of gene therapy for rare diseases,…
With healthcare becoming more and more personalized, industry stakeholders are looking for new ways…
2:00 PM - 3:00 PM
Microbiome research is one of the hottest areas in biology, but do we really understand enough…
All-time high valuations offer biopharma companies a window of opportunity to re-assess their…
An investor once said, “You can replace an executive, but you can’t replace a founder.” Founders of…
Research has a data problem. It is increasingly clear that there are issues with the robustness,…
Emerging innovative companies in the pharma/biotech field face earlier generic competition than…
Overcoming obstacles that hinder integration of real world data into current clinical development…
Many pharma companies partner with diagnostic companies to develop, manufacture and commercialize…
In 2045, more than 50% of the US population will be Hispanic, Black, Asian and multiracial—up from…
Infectious Disease diagnostics face different fiscal pressures, economic considerations, and…
In the fall of 2018 Congress passed the Substance Use-Disorder Prevention that Promotes Opioid…
From human genome editing to cell and gene therapies, innovation in the biotechnology industry is…
Join Wainwright Fishburn for a digital health market snapshot, followed by an in-depth discussion…
Leading industrial biotech firms will discuss transformations in health and wellness stemming from…
2:00 PM - 3:30 PM
Ability to store, merge and analyze large volumes of data allows to introduce efficiencies into…
3:15 PM - 4:15 PM
Patient engagement, although highly promoted across many health sectors, often lacks a clear…
The Opioid Crisis has had grave effects on both the public health and the well-being of our society…
There are more than 600 neurological disorders that impact millions of patients and families across…
Valuing early-stage opportunities is challenging. Modeling will often provide a false sense of…
The current biotech boom has conceived many innovative therapeutics, but we still lack an effective…
The Supreme Court and the Federal Circuit Courts continue to issue opinions on a variety of hot IP…
We are beginning to understand the biological basis of aging and age-related diseases, making the…
This Session will discuss financing approaches for developing and commercializing innovative…
Join us for a conversation with Peter Saltonstall, President and Chief Executive Officer at the…
3:15 PM - 4:45 PM
Leading healthcare institutions in the Philadelphia region discuss how they are leveraging digital…
4:30 PM - 5:30 PM
The sun never sets on your patent portfolio! This session will circumnavigate the globe and provide…
The advent of patient-focused drug development has underscored the priority of engaging the patient…
In recent years global innovation hubs and biomedical clusters have developed collaborative…
Oncology has always been one of the hottest research areas in pharma. As of August 2018, 40% of the…
Mind-body research began moving into the mainstream over a decade ago and it’s commonly understood…
Orphan Drug development has escalated at a rapid pace in recent years with over 500 products on the…
Over the course of 2018 and 2019, the Food and Drug Administration (FDA) has proposed and…
Wednesday, June 5
11:00 AM - 12:00 PM
Spark Therapeutics commercially launched the first gene therapy for a genetic disease in the US and…
Precision Medicine has helped transform cancer care from one-size-fits-all chemotherapy to a new…
How is the biotech sector likely to be impacted by Brexit, both in the UK and the EU? This panel…
This session will discuss the spectrum of technologies, both short and long term, that would help…
This panel will provide insights on the distinct contributions of patient experience data and real…
The American Society of Clinical Oncology’s (ASCO) Annual Meeting brings together more than 30,000…
105AB, Level 100
A spirited debate, new and evolving methods, and a better appreciation of the role patients play…
There are thousands of genetic diseases for which there is no treatment. Genome editing is a…
Potential benefits of Big Data applications in the field of pharmaceutical research is not only in…
The session will address: • Why deprioritized compounds still offer the potential to help address…
11:00 AM - 12:15 PM
As care for lifestyle-driven chronic diseases expands in scope, prevention and recovery are…
Emerging company investment for drug development in highly prevalent chronic diseases is shown to…
1:45 PM - 2:45 PM
Human gene editing continues to hold a major fascination within a biomedical and biopharmaceutical…
Payers are evaluating provider and reimbursement policies, seeking value in precision health. This…
As larger biotech and pharmaceutical companies seek to expand or strengthen their product…
With multiple oncology "first launch" successes in recent years, most oncology emerging pharma…
105AB, Level 100
The impact of Machine Learning (ML) and Artificial Intelligence (AI) during the last decade has…
How can big pharma bring the most value to new and innovative research and match the rapid pace of…
A central challenge of rare disease drug development is not having enough patients to conduct…
Cardiovascular-renal disease is the leading cause of death worldwide resulting in a massive…
This session will focus on the scientific and clinical progress of novel platform technologies. …
According to research from the US Health and Human Services, US tax payers pay 1.8 times the…
India has invested significant resources in erecting a biotechnology infrastructure from its…
Since the first CAR T cell therapy was approved by the FDA in 2017, we’ve witnessed what was once…
3:00 PM - 4:00 PM
Increased patient engagement in medicine development and regulatory approval decisions is occurring…
Productive collaborations between biotech and major pharma provide a long-term competitive…
While life sciences directed technology-based economic development (TBED) organizations have…
Advances in genetics have altered the landscape for newborn screening, giving families new hope of…
It is widely accepted that early cancer detection improves treatment options and increases 5-year…
105AB, Level 100
The science driving personalized medicine continues to push innovation in the advanced diagnostics…
Artifical Intelligence (AI) is deeply impacting how biopharma companies operate in drug discovery…
Genome editing offers the potential of new and effective treatments for genetic diseases. As…
With drug pipelines slimming down in the face of complex and costly Phase IIIs and investors weary…
Cross-border collaboration between U.S. and Japan in the biopharma sector has intensified in recent…
Increasingly, innovative medicines are coming to market introducing new modalities that are…
The US is the global leader in ensuring patients have comprehensive access to the newest therapies…
4:15 PM - 5:15 PM
When children fall ill, they deserve to receive treatments that are both safe and effective. Yet 50…
The march to make cancer a chronic condition is progressing but true success thus far has been…
This session addresses the landscape for regulatory approval of Laboratory Developed Tests (LDTs)…
Given the relatively high cost of rare disease treatments, payers play an increasingly important…
Referencing European prices for Medicare Part B drugs is a possible approach for drug pricing…
There is significant unmet need for new therapies for the treatment of depression. Only 29 active…
Clinical trials are designed to measure for multiple endpoints including overall survival (OS),…
105AB, Level 100
Thursday, June 6
9:00 AM - 10:15 AM
Artificial Intelligence (AI) is transforming virtually all sectors of modern society, including…
Personalized Medicine in cancer care rests on the assumption that genomic profiling can aid in…
As discovery and development of cancer drugs continues to explode, cost pressures continue to mount…
105AB, Level 100
There's no denying that investments and drug development in rare and orphan diseases have increased…
Biotechs working in early stage drug development are tapping into new sources of funding. Family…
10:30 AM - 11:45 AM
Head turning deals in precision medicine typically result in competitor companies analyzing every…
Digital Health innovation has the potential to transform patient care and lower healthcare costs…
Even as the FDA and other government agencies have incentivized drug development for rare diseases,…
This session will bring together traditional and corporate venture capitalists to share…
Cell and gene therapies have the potential to change the therapy landscape in many therapeutic…
10:30 AM - 12:00 PM
We have seen great strides in the approval of cancer immunotherapies, treatments that harness the…
105AB, Level 100
India is looking to regulate cell and gene therapies as drugs. The panel of experts will discuss…